We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GROV icon
3851
Grove Collaborative
GROV
$46.1M
$260K ﹤0.01%
155,778
-1,606
-1% -$2.96K
TISI icon
3852
Team
TISI
$77.7M
$259K ﹤0.01%
35,934
NOA
3853
North American Construction
NOA
$395M
$258K ﹤0.01%
11,598
-5,303
-31% -$123K
VIRX
3854
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$258K ﹤0.01%
252,701
MAQC
3855
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$258K ﹤0.01%
23,541
BLTE
3856
Belite Bio
BLTE
$6.54B
$257K ﹤0.01%
6,700
RBKB icon
3857
Rhinebeck Bancorp
RBKB
$194M
$256K ﹤0.01%
30,312
+1,272
+4% +$10.8K
LINK icon
3858
Interlink Electronics
LINK
$80.3M
$254K ﹤0.01%
51,932
-990
-2% -$5.29K
LPCN icon
3859
Lipocine
LPCN
$17.6M
$254K ﹤0.01%
48,854
TPCS icon
3860
TechPrecision Corp
TPCS
$49.7M
$254K ﹤0.01%
70,334
+820
+1% +$3.29K
AP icon
3861
Ampco-Pittsburgh
AP
$193M
$254K ﹤0.01%
116,895
+2,278
+2% +$5.72K
ORKA
3862
Oruka Therapeutics
ORKA
$5.96B
$253K ﹤0.01%
11,862
FGNX
3863
FG Nexus Inc
FGNX
$38.7M
$252K ﹤0.01%
1,460
+1,204
+470% +$207K
FATBB
3864
DELISTED
FAT Brands
FATBB
$250K ﹤0.01%
62,766
BODI icon
3865
The Beachbody Company
BODI
$74.8M
$249K ﹤0.01%
25,916
+1,868
+8% +$17.7K
INTS icon
3866
Intensity Therapeutics
INTS
$11.2M
$248K ﹤0.01%
1,905
+91
+5% +$10.9K
XOS icon
3867
Xos
XOS
$37.7M
$247K ﹤0.01%
24,084
+2,974
+14% +$27.9K
PMGM
3868
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$246K ﹤0.01%
22,542
CVII
3869
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$245K ﹤0.01%
+22,936
New +$243K
SOAR icon
3870
Volato Group
SOAR
$7.23M
$244K ﹤0.01%
+2,754
New +$230K
NAII icon
3871
Natural Alternatives International
NAII
$14.9M
$244K ﹤0.01%
40,123
BZFD icon
3872
BuzzFeed
BZFD
$96.7M
$243K ﹤0.01%
129,982
+3,147
+2% +$3.55K
KULR icon
3873
KULR Technology Group
KULR
$135M
$242K ﹤0.01%
79,743
CMAX
3874
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$242K ﹤0.01%
50,293
-1,810
-3% -$15.2K
DAIO icon
3875
Data I/O
DAIO
$30.6M
$241K ﹤0.01%
68,393
+2,117
+3% +$6.93K

Similar funds

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.